Show channels:
All channels
Bladder cancer
Brain and spinal
Breast cancer
Cervical
Colon & rectal
Dermatological
General Information
Gynecological
Head and Neck
Kidney/adrenal
Liver
Lung
Lymphoma
Multiple Myeloma
Myelodysplastic syndromes
Myeloproliferative disorders
Pancreas
Pediatric
Prostate
Sarcoma
Stomach
Testicular
Thyroid
Upper aerodigestive
Found 15815 articles
NOTCH pathway inactivation promotes bladder cancer progression.
NOTCH serves as a tumor suppressor in the bladder.
»
07/23/14
Role of osteopontin in the regulation of human bladder cancer proliferation and migration in T24 cells.
RNAi‑targeting OPN may inhibit tumorigenicity of human bladder cancer cells.
»
02/19/14
KEAP1 genetic polymorphisms associate with breast cancer risk and survival outcomes.
SNPs have effects related to oxidative stress induced by cancer treatment.
»
01/16/15
Interferon Regulatory Factor-1 signaling regulates the switch between autophagy and apoptosis to determine breast cancer cell fate.
Inhibiting the autophagy proteins ATG7 and BECN1 can regulate IRF1 dependent and independent signaling pathways.
»
01/11/15
Loss of MyD88 leads to more aggressive TRAMP prostate cancer and influences tumor infiltrating lymphocytes.
Absence of MyD88 led to increased prostatic intraepithelial neoplasm.
»
08/06/14
Expression profile analysis of microRNAs in prostate cancer by next-generation sequencing.
Study uncovers six differentially expressed miRNAs and 12 novel miRNAs.
»
09/25/14
A novel wnt regulatory axis in endometrioid endometrial cancer.
MALAT1 transcription was regulated by Wnt/β-catenin signaling via TCF promoter binding.
»
08/01/14
Starvation promotes REV1 SUMOylation and p53-dependent sensitization of melanoma and breast cancer cells.
REV1 is a novel binding partner of the tumor suppressor p53.
»
01/24/15
Incidence of T790M mutation in (sequential) rebiopsies in EGFR-mutated NSCLC-patients.
Incidence of T790M-mutation at first post-TKI biopsy in this cohort of EGFR-mutated NSCLC-patients was 52%.
»
12/10/13
TIGAR has a dual role in cancer cell survival through regulating apoptosis and autophagy.
TIGAR silencing also licensed epirubicin-mediated inactivation of the mTOR pathway.
»
08/01/14
< Prev
Next >